Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain

被引:122
作者
Liang, Zhihou [1 ]
Liu, Fei [1 ]
Grundke-Iqbal, Inge [1 ]
Iqbal, Khalid [1 ]
Gong, Cheng-Xin [1 ]
机构
[1] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA
关键词
Alzheimer disease; calpain; cAMP-response; element-binding protein; protein kinase;
D O I
10.1111/j.1471-4159.2007.04942.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Impaired cognition and memory may be associated with down-regulation of cAMP-response element-binding protein (CREB) in the brain in patients with Alzheimer disease, but the molecular mechanism leading to the down-regulation is not understood. In this study, we found a selective reduction in the levels of the regulatory subunits (RII alpha and RII beta) and the catalytic subunit (C beta) as well as the enzymatic activity of cAMP-dependent protein kinase (PKA), which is the major positive regulator of CREB. We also observed that PKA subunits were proteolyzed by calpain and the levels of PKA subunits correlated negatively with calpain activation in the human brain. These findings led us to propose that in the brain in patients with Alzheimer disease, over-activation of calpain because of calcium dysregulation causes increased degradation and thus decreased activity of PKA, which, in turn, contributes to down-regulation of CREB and impaired cognition and memory.
引用
收藏
页码:2462 / 2470
页数:9
相关论文
共 42 条
  • [1] Protein kinase Cα is a calpain target in cultured embryonic muscle cells
    Aragon, B
    Poussard, S
    Dulong, S
    Touyarot, K
    Dargelos, E
    Brustis, JJ
    Levieux, D
    Ducastaing, A
    Cottin, P
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2002, 231 (1-2) : 97 - 106
  • [2] CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects
    Barco, A
    Pittenger, C
    Kandel, ER
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (01) : 101 - 114
  • [3] STAGING OF ALZHEIMERS-DISEASE-RELATED NEUROFIBRILLARY CHANGES
    BRAAK, H
    BRAAK, E
    [J]. NEUROBIOLOGY OF AGING, 1995, 16 (03) : 271 - 278
  • [4] Type II regulatory subunits are not required for the anchoring-dependent modulation of Ca2+ channel activity by cAMP-dependent protein kinase
    Burton, KA
    Johnson, BD
    Hausken, ZE
    Westenbroek, RE
    Idzerda, RL
    Scheuer, T
    Scott, JD
    Catterall, WA
    McKnight, GS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 11067 - 11072
  • [5] DISTINCT PATTERNS OF CAMP-DEPENDENT PROTEIN-KINASE GENE-EXPRESSION IN MOUSE-BRAIN
    CADD, G
    MCKNIGHT, GS
    [J]. NEURON, 1989, 3 (01) : 71 - 79
  • [6] Altered cAMP-dependent protein kinase subunit immunolabeling in post-mortem brain from patients with bipolar affective disorder
    Chang, A
    Li, PP
    Warsh, JJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 84 (04) : 781 - 791
  • [7] THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES
    COHEN, P
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 : 453 - 508
  • [8] LOCALIZATION OF THE CATALYTIC SUBUNIT-C-GAMMA OF THE CAMP-DEPENDENT PROTEIN-KINASE GENE (PRKACG) TO HUMAN-CHROMOSOME REGION-9Q13
    FOSS, KB
    SIMARD, J
    BERUBE, D
    BEEBE, SJ
    SANDBERG, M
    GRZESCHIK, KH
    GAGNE, R
    HANSSON, V
    JAHNSEN, T
    [J]. CYTOGENETICS AND CELL GENETICS, 1992, 60 (01): : 22 - 25
  • [9] The major catalytic subunit isoforms of cAMP-dependent protein kinase have distinct biochemical properties in vitro and in vivo
    Gamm, DM
    Baude, EJ
    Uhler, MD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (26) : 15736 - 15742
  • [10] Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment
    Gong, B
    Vitolo, OV
    Trinchese, F
    Liu, SM
    Shelanski, M
    Arancio, O
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (11) : 1624 - 1634